Serum vascular endothelial growth factor b and metabolic syndrome incidence in the population based cohort [e-mail] study.

ABSTRACT:

Background/objectives

Although vascular endothelial growth factor b (VEGFb) might have an impact on the development of obesity, diabetes and related disorders, the possible relationship between VEGFb serum levels and the incidence of these metabolic complications in humans is still unknown. The aim of our study was to evaluate the association between VEGFb serum levels and the new-onset of metabolic syndrome (MS) and its components in the Spanish adult population after 7.5 years of follow-up.

Subjects/methods

A total of 908 subjects from the [e-mail] cohort study without MS at cross-sectional stage according to International Diabetes Federation (IDF) or Adult Treatment Panel III (ATP-III) criteria were included. Additionally, five sub-populations were grouped according to t

SUBMITTER: Lago-Sampedro A 

PROVIDER: S-EPMC9584818 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature